Ligand profile
6NM
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_0681 — alpha/beta hydrolase fold family protein
Identifiers
Database identifiers and provenance.
- Ligand ID
6NM- PDB
5akh- UniProt (similar protein)
P34913- Target protein
- VK055_0681
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 41.6
- −1 ≤ LogP ≤ 5 4.16
- MW ≤ 500 Da 289.3
- LogP ≤ 5 4.16
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 41.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1cc(cc(c1)C(F)(F)F)c2c(cn[nH]2)c3ccncc3c1cc(cc(c1)C(F)(F)F)c2c(cn[nH]2)c3ccncc3
InChI=1S/C15H10F3N3/c16-15(17,18)12-3-1-2-11(8-12)14-13(9-20-21-14)10-4-6-19-7-5-10/h1-9H,(H,20,21)InChI=1S/C15H10F3N3/c16-15(17,18)12-3-1-2-11(8-12)14-13(9-20-21-14)10-4-6-19-7-5-10/h1-9H,(H,20,21)
UZOPNNYVHHABCA-UHFFFAOYSA-NUZOPNNYVHHABCA-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00561
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 6NM →
- PDB RCSB structure 5akh →
- UniProt UniProt P34913 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “6NM”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_0681.
PDB 98
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).